Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 10.35
-0.30 (-2.82%)
Mar 4, 2026, 2:19 PM CST
TPEX:4186 Market Cap
TPEX:4186 has a market cap or net worth of 927 million as of March 4, 2026. Its market cap has decreased by -36.02% in one year.
Market Cap
927.00M
Enterprise Value
1.07B
Revenue
371.86M
Ranking
n/a
PE Ratio
40.27
Stock Price
10.35
Market Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 927.00M, a decrease of -77.38%. That is a compound annual growth rate of -10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 958.50M | -4.48% |
| Dec 31, 2025 | 1.00B | -29.21% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.31B |
| GeneReach Biotechnology | 1.15B |
| Lukas Biomedical | 1.12B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 1.06B |
| TCI GENE | 1.01B |
| NatureWise Biotech & Medicals | 944.75M |
| Eusol Biotech | 930.23M |